E

EP-SOGO Co., Ltd. | Nagoya City University Hospital

Research site
(Unclaimed)
Location
Mizuho-ku,Kawasumi 1, Nagoya, Aichi, Japan
Site insights

Top conditions

Multiple Myeloma (8 trials)

Plasma Cell Cancer (7 trials)

Psoriasis (3 trials)

Pulmonary Arterial Hypertension (1 trial)

Prostatic Cancer (1 trial)

Top treatments

Dexamethasone
Bortezomib
Daratumumab
JNJ-77242113
Lenalidomide
Teclistamab
VRd
Pomalidomide
DPd
JNJ-73763989

Parent organization

This site is a part of EP-SOGO Co., Ltd.

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

14 of 16
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-c...

Enrolling
Multiple Myeloma
Drug: Cilta-cel

The purpose of this study to determine if the addition of daratumumab to bortezomib + lenalidomide + dexamethasone (VRd) will improve overall minimal...

Active, not recruiting
Multiple Myeloma
Drug: Lenalidomide
Drug: Daratumumab

The purpose of this study is to compare the efficacy of JNJ-68284528 (ciltacabtagene autoleucel [cilta-cel]) with standard therapy, either Pomalidomi...

Active, not recruiting
Multiple Myeloma
Drug: Daratumumab
Drug: Bortezomib

The purpose of this study is to compare the efficacy of Bortezomib, Lenalidomide and Dexamethasone (VRd) induction followed by a single administratio...

Enrolling
Multiple Myeloma
Drug: Cyclophosphamide
Drug: Cilta-cel

The purpose of this study is to evaluate the efficacy and safety of guselkumab in participants with moderately to severely active ulcerative colitis...

Active, not recruiting
Ulcerative Colitis
Drug: Guselkumab
Drug: Placebo

The purpose of this study is to evaluate the safety and tolerability in Japanese participants with relapsed or refractory multiple myeloma (MM) at th...

Active, not recruiting
Multiple Myeloma
Drug: Talquetamab

The purpose of this study is to evaluate how effective JNJ-77242113 is in participants with generalized pustular psoriasis (GPP) or erythrodermic pso...

Enrolling
Generalized Pustular Psoriasis
Erythrodermic Psoriasis
Drug: JNJ-77242113

The purpose of the study is to see how effective JNJ-77242113 is in participants with moderate to severe plaque psoriasis compared to placebo and deu...

Enrolling
Plaque Psoriasis
Drug: Deucravacitinib Matching Placebo
Drug: JNJ-77242113

The purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.

Enrolling
Plaque Psoriasis
Drug: JNJ-77242113
Drug: Placebo

The primary objective of this study is to determine whether treatment with daratumumab administered subcutaneously (SC) prolongs progression-free sur...

Active, not recruiting
Smoldering Multiple Myeloma
Drug: Daratumumab SC: daratumumab + rHuPH20

The purpose of this study is to compare the efficacy of teclistamab daratumumab (Tec-Dara) with daratumumab subcutaneously (SC) in combination with p...

Active, not recruiting
Multiple Myeloma
Drug: Dexamethasone
Drug: Teclistamab

The purpose of this study is to identify the recommended Phase 2 regimen(s) (RP2R[s]) and schedule for the study treatment (Part 1), to characterize...

Enrolling
Multiple Myeloma
Drug: Talquetamab
Drug: Teclistamab

The purpose of this study is to evaluate the efficacy and safety of daratumumab plus cyclophosphamide, bortezomib and dexamethasone (CyBorD) compared...

Active, not recruiting
Amyloidosis
Drug: Cyclophosphamide
Drug: Daratumumab

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committe...

Enrolling
Pulmonary Arterial Hypertension
Drug: Macitentan 75 mg
Drug: Macitentan 10 mg

Trial sponsors

Janssen logo

Janssen (12 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems